|
1
|
Yu D, Wong YM, Cheong Y, Xia E and Li TC:
Asherman syndrome - one century later. Fertil Steril. 89:759–779.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
March CM: Asherman's syndrome. Semin
Reprod Med. 29:83–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang CC, Orvis GD, Wang Y and Behringer
RR: Stromal-to-epithelial transition during postpartum endometrial
regeneration. PLoS One. 7:e442852012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Germeyer A, Sharkey AM, Prasadajudio M,
Sherwin R, Moffett A, Bieback K, Clausmeyer S, Masters L, Popovici
RM, Hess AP, et al: Paracrine effects of uterine leucocytes on gene
expression of human uterine stromal fibroblasts. Mol Hum Reprod.
15:39–48. 2009. View Article : Google Scholar
|
|
5
|
Kamato D, Burch ML, Piva TJ, Rezaei HB,
Rostam MA, Xu S, Zheng W, Little PJ and Osman N: Transforming
growth factor-β signalling: Role and consequences of Smad linker
region phosphorylation. Cell Signal. 25:2017–2024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andrieux G, Fattet L, Le Borgne M, Rimokh
R and Théret N: Dynamic regulation of Tgf-B signaling by Tif1γ: A
computational approach. PLoS One. 7:e337612012. View Article : Google Scholar
|
|
7
|
Muro AF, Moretti FA, Moore BB, Yan M,
Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, Sheppard D,
et al: An essential role for fibronectin extra type III domain A in
pulmonary fibrosis. Am J Respir Crit Care Med. 177:638–645. 2008.
View Article : Google Scholar
|
|
8
|
Tao Z and Duan H: Expression of
adhesion-related cytokines in the uterine fluid after transcervical
resection of adhesion. Zhonghua Fu Chan Ke Za Zhi. 47:734–737.
2012.In Chinese.
|
|
9
|
He Y, Huang C, Lin X and Li J: MicroRNA-29
family, a crucial therapeutic target for fibrosis diseases.
Biochimie. 95:1355–1359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang B, Komers R, Carew R, Winbanks CE, Xu
B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K,
Gregorevic P, et al: Suppression of microRNA-29 expression by
TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc
Nephrol. 23:252–265. 2012. View Article : Google Scholar :
|
|
12
|
Roderburg C, Urban GW, Bettermann K, Vucur
M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi
M, et al: Micro-RNA profiling reveals a role for miR-29 in human
and murine liver fibrosis. Hepatology. 53:209–218. 2011. View Article : Google Scholar
|
|
13
|
Xiao J, Meng XM, Huang XR, Chung AC, Feng
YL, Hui DS, Yu CM, Sung JJ and Lan HY: miR-29 inhibits
bleomycin-induced pulmonary fibrosis in mice. Mol Ther.
20:1251–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ
and Lan HY: MicroRNA-29b inhibits peritoneal fibrosis in a mouse
model of peritoneal dialysis. Lab Invest. 94:978–990. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu
BM, Xu FY, Zhang L, Lv XW and Li J: Inhibitory effects of long
noncoding RNA MEG3 on hepatic stellate cells activation and liver
fibrogenesis. Biochim Biophys Acta. 1842.2204–2215. 2014.
|
|
17
|
Zhou M, He Y and Liu F: Expression and
significance of miR-29a, TGF-β1, Smad2 and Smad3 in endometrium of
patient with intrauterine adhesions. Shi Yong Yi Xue Za Zhi.
30:1231–1234. 2014.In Chinese.
|
|
18
|
Ryan IP, Schriock ED and Taylor RN:
Isolation, characterization, and comparison of human endometrial
and endometriosis cells in vitro. J Clin Endocrinol Metab.
78:642–649. 1994.PubMed/NCBI
|
|
19
|
Park DW, Choi DS, Ryu HS, Kwon HC, Joo H
and Min CK: A well-defined in vitro three-dimensional culture of
human endometrium and its applicability to endometrial cancer
invasion. Cancer Lett. 195:185–192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Liu Y, Taylor NE, Lu L, Usa K, Cowley AW
Jr, Ferreri NR, Yeo NC and Liang M: Renal medullary microRNAs in
Dahl salt-sensitive rats: miR-29b regulates several collagens and
related genes. Hypertension. 55:974–982. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Verrecchia F and Mauviel A: Transforming
growth factor-beta and fibrosis. World J Gastroenterol.
13:3056–3062. 2007.PubMed/NCBI
|
|
23
|
Kwiecinski M, Noetel A, Elfimova N,
Trebicka J, Schievenbusch S, Strack I, Molnar L, von Brandenstein
M, Töx U, Nischt R, et al: Hepatocyte growth factor (HGF) inhibits
collagen I and IV synthesis in hepatic stellate cells by miRNA-29
induction. PLoS One. 6:e245682011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gressner AM and Weiskirchen R: Modern
pathogenetic concepts of liver fibrosis suggest stellate cells and
TGF-beta as major players and therapeutic targets. J Cell Mol Med.
10:76–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin W, Chung AC, Huang XR, Meng XM, Hui
DS, Yu CM, Sung JJ and Lan HY: TGF-β/Smad3 signaling promotes renal
fibrosis by inhibiting miR-29. J Am Soc Nephrol. 22:1462–1474.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kriegel AJ, Liu Y, Fang Y, Ding X and
Liang M: The miR-29 family: Genomics, cell biology, and relevance
to renal and cardiovascular injury. Physiol Genomics. 44:237–244.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luna C, Li G, Qiu J, Epstein DL and
Gonzalez P: Role of miR-29b on the regulation of the extracellular
matrix in human trabecular meshwork cells under chronic oxidative
stress. Mol Vis. 15:2488–2497. 2009.PubMed/NCBI
|
|
28
|
Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM
and Lan HY: miR-29b as a therapeutic agent for angiotensin
II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Mol
Ther. 22:974–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
